(Q45749994)

English

High pre-treatment serum hepatitis B virus titre predicts failure of lamivudine prophylaxis and graft re-infection after liver transplantation

scientific article published in April 1999

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

15 December 2017

http://europepmc.org/abstract/MED/10207815

High pre-treatment serum hepatitis B virus titre predicts failure of lamivudine prophylaxis and graft re-infection after liver transplantation (English)

1 reference

Europe PubMed Central

15 December 2017

http://europepmc.org/abstract/MED/10207815

liver transplantation

1 reference

based on heuristic

inferred from title

Hepatitis B virus

1 reference

based on heuristic

inferred from title

1 reference

based on heuristic

inferred from title

1 reference

based on heuristic

inferred from title

author name string

Mutimer D

1

1 reference

Europe PubMed Central

15 December 2017

http://europepmc.org/abstract/MED/10207815

Pillay D

2

1 reference

Europe PubMed Central

15 December 2017

http://europepmc.org/abstract/MED/10207815

Dragon E

3

1 reference

Europe PubMed Central

15 December 2017

http://europepmc.org/abstract/MED/10207815

Tang H

4

1 reference

Europe PubMed Central

15 December 2017

http://europepmc.org/abstract/MED/10207815

Ahmed M

5

1 reference

Europe PubMed Central

15 December 2017

http://europepmc.org/abstract/MED/10207815

O'Donnell K

6

1 reference

Europe PubMed Central

15 December 2017

http://europepmc.org/abstract/MED/10207815

Shaw J

7

1 reference

Europe PubMed Central

15 December 2017

http://europepmc.org/abstract/MED/10207815

Burroughs N

8

1 reference

Europe PubMed Central

15 December 2017

http://europepmc.org/abstract/MED/10207815

Rand D

9

1 reference

Europe PubMed Central

15 December 2017

http://europepmc.org/abstract/MED/10207815

Cane P

10

1 reference

Europe PubMed Central

15 December 2017

http://europepmc.org/abstract/MED/10207815

Martin B

11

1 reference

Europe PubMed Central

15 December 2017

http://europepmc.org/abstract/MED/10207815

Buchan S

12

1 reference

Europe PubMed Central

15 December 2017

http://europepmc.org/abstract/MED/10207815

Boxall E

13

1 reference

Europe PubMed Central

15 December 2017

http://europepmc.org/abstract/MED/10207815

Barmat S

14

1 reference

Europe PubMed Central

15 December 2017

http://europepmc.org/abstract/MED/10207815

Gutekunst K

15

1 reference

Europe PubMed Central

15 December 2017

http://europepmc.org/abstract/MED/10207815

McMaster P

16

1 reference

Europe PubMed Central

15 December 2017

http://europepmc.org/abstract/MED/10207815

Elias E

17

1 reference

Europe PubMed Central

15 December 2017

http://europepmc.org/abstract/MED/10207815

publication date

1 April 1999

1 reference

Europe PubMed Central

15 December 2017

http://europepmc.org/abstract/MED/10207815

Journal of Hepatology

1 reference

Europe PubMed Central

15 December 2017

http://europepmc.org/abstract/MED/10207815

30

1 reference

Europe PubMed Central

15 December 2017

http://europepmc.org/abstract/MED/10207815

4

1 reference

Europe PubMed Central

15 December 2017

http://europepmc.org/abstract/MED/10207815

715-721

1 reference

Europe PubMed Central

15 December 2017

http://europepmc.org/abstract/MED/10207815

Liver transplantation in HBs antigen (HBsAg) carriers. Prevention of hepatitis B virus (HBV) recurrence by passive immunization

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8278%2899%2980204-9

7 January 2021

based on heuristic

inferred from DOI database lookup

Liver transplantation in European patients with the hepatitis B surface antigen

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8278%2899%2980204-9

7 January 2021

based on heuristic

inferred from DOI database lookup

Recurrent hepatitis B in liver allografts: a distinctive form of rapidly developing cirrhosis

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8278%2899%2980204-9

7 January 2021

based on heuristic

inferred from DOI database lookup

Hepatic histological findings after transplantation for chronic hepatitis B virus infection, including a unique pattern of fibrosing cholestatic hepatitis

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8278%2899%2980204-9

7 January 2021

based on heuristic

inferred from DOI database lookup

Liver transplantation for hepatitis B: the con aspect

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8278%2899%2980204-9

7 January 2021

based on heuristic

inferred from DOI database lookup

Lamivudine therapy for chronic hepatitis B: a six-month randomized dose-ranging study

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8278%2899%2980204-9

7 January 2021

based on heuristic

inferred from DOI database lookup

A preliminary trial of lamivudine for chronic hepatitis B infection

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8278%2899%2980204-9

7 January 2021

based on heuristic

inferred from DOI database lookup

Lamivudine prophylaxis against reinfection in liver transplantation for hepatitis B cirrhosis

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8278%2899%2980204-9

7 January 2021

based on heuristic

inferred from DOI database lookup

Selection of mutations in the hepatitis B virus polymerase during therapy of transplant recipients with lamivudine

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8278%2899%2980204-9

7 January 2021

based on heuristic

inferred from DOI database lookup

Hepatitis-B-virus resistance to lamivudine given for recurrent infection after orthotopic liver transplantation

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8278%2899%2980204-9

7 January 2021

based on heuristic

inferred from DOI database lookup

Emergence and takeover of YMDD motif mutant hepatitis B virus during long-term lamivudine therapy and re-takeover by wild type after cessation of therapy

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8278%2899%2980204-9

7 January 2021

based on heuristic

inferred from DOI database lookup

Viral dynamics in hepatitis B virus infection

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8278%2899%2980204-9

7 January 2021

based on heuristic

inferred from DOI database lookup

Dynamics of hepatitis B virus infection in vivo

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8278%2899%2980204-9

7 January 2021

based on heuristic

inferred from DOI database lookup

Lower in vivo mutation rate of human immunodeficiency virus type 1 than that predicted from the fidelity of purified reverse transcriptase

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8278%2899%2980204-9

7 January 2021

based on heuristic

inferred from DOI database lookup

Direct determination of the point mutation rate of a murine retrovirus

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8278%2899%2980204-9

7 January 2021

based on heuristic

inferred from DOI database lookup

Prophylaxis against hepatitis B recurrence following liver transplantation using combination lamivudine and hepatitis B immune globulin

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8278%2899%2980204-9

7 January 2021

based on heuristic

inferred from DOI database lookup

Identifiers

10.1016/S0168-8278(99)80204-9

1 reference

Europe PubMed Central

15 December 2017

http://europepmc.org/abstract/MED/10207815

1 reference

Europe PubMed Central

15 December 2017

http://europepmc.org/abstract/MED/10207815

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q45749994&oldid=2080949244"